Constitutional genomic instability, chromosome aberrations in tumor cells and retinoblastoma

Cancer Genetics and Cytogenetics

Volumn 150, Issue 1, 2004, Pages 33-43

  Amare, P S ^a   Ghule, P ^a   Jose, J ^a   Bamne, M ^a   Kurkure, P ^a   Banavali, S ^a   Sarin, R ^a   Advani, S ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME IDENTIFICATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOGENETICS; FEMALE; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENETIC COUNSELING; GENOMICS; HUMAN; HUMAN CELL; MALE; PREVALENCE; PRIORITY JOURNAL; RETINOBLASTOMA; TUMOR CELL;

ADOLESCENT; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN; FEMALE; GENOMIC INSTABILITY; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; INFANT, NEWBORN; KARYOTYPING; LEUKOCYTES; MALE; MOSAICISM; RETINAL NEOPLASMS; RETINOBLASTOMA; RETINOBLASTOMA PROTEIN;

EID: 1642352674     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2003.08.015     Document Type: Article

References (53)

1. Lohmann D.R. RB1 gene mutations in retinoblastoma. Hum Mutat. 14:1999;283-288.
2. Balaban-Malenbaum G., Gilbert F., Nichols W.W., Hill R., Shields J., Meadows A.T. A deleted chromosome no. 13 in human retinoblastoma cells: relevance to tumorigenesis. Cancer Genet Cytogenet. 3:1981;243-250.
3. Benedict W.F., Banerjee A., Mark C., Murphree A.L. Nonrandom chromosomal changes in untreated retinoblastomas. Cancer Genet Cytogenet. 10:1983;311-313.
4. Chaum E., Ellsworth R.M., Abramson D.H., Haik B.G., Kitchin F.D., Chaganti R.S. Cytogenetic analysis of retinoblastoma: evidence for multifocal origin and in vivo gene amplification. Cytogenet Cell Genet. 38:1984;82-91.
5. Squire J., Gallie B.L., Phillips R.A. A detailed analysis of chromosomal changes in heritable and non-heritable retinoblastoma. Hum Genet. 70:1985;291-301.
6. Yunis J.J. The chromosomal basis of human neoplasia. Science. 221:1983;227-236.
7. Le Beau M.M., Rowley J.D. Heritable fragile sites in cancer. Nature. 308:1984;607-608.
8. Kovacs G., Brusa P., De Riese W. Tissue-specific expression of a constitutional 3;6 translocation: development of multiple bilateral renal-cell carcinomas. Int J Cancer. 43:1989;422-427.
9. Pathak S., Goodacre A. Specific chromosome anomalies and predisposition to human breast, renal cell, and colorectal carcinoma. Cancer Genet Cytogenet. 19:1986;29-36.
10. Sundareshan T.S., Augustus M. Expression of fragile sites in patients with retinoblastoma, their parents and unaffected siblings: a survey of ten families. Cancer Genet Cytogenet. 78:1994;72-77.
11. Schultz K.R., Ranade S., Neglia J.P., Ravindranath Y. An increased relative frequency of retinoblastoma at a rural regional referral hospital in Miraj, Maharashtra, India. Cancer. 72:1993;282-286.
12. Orjuela M., Castaneda V.P., Ridaura C., Lecona E., Leal C., Abramson D.H., Orlow I., Gerald W., Cordon-Cardo C. Presence of human papilloma virus in tumor tissue from children with retinoblastoma: an alternative mechanism for tumor development. Clin Cancer Res. 6:2000;4010-4016.
13. Stiller C., Parkir D. Geographic and ethnic variations in the incidence of childhood cancer. Br Med Bull. 52:1996;682-703.
14. Bunin G.R., Emanuel B.S., Meadows A.T., Buckley J.D., Woods W.G., Hammond G.D. Frequency of 13q abnormalities among 203 patients with retinoblastoma. J Natl Cancer Inst. 81:1989;370-374.
15. Johnson M.P., Ramsay N., Cervenka J., Wang N. Retinoblastoma and its association with deletion in chromosome 13: a survey using high-resolution chromosome techniques. Cancer Genet Cytogenet. 6:1982;29-37.
16. Motegi T. High rate of detection of 13q14 deletion mosaicism among retinoblastoma patients (using more extensive methods). Hum Genet. 61:1982;95-97.
17. Mitelman F. International system for human cytogenetics nomenclature. 1995;S. Karger, Basel.
18. Amare (Kadam) P., Jose J., Chitalkar P., Kurkure P., Pai S., Nair C., Advani S. Trilateral retinoblastoma with an RB1 deletion inherited from a carrier mother: a case report. Cancer Genet Cytogenet. 111:1999;28-31.
19. Couturier J., Morichon-Delvallez N., Dutrillaux B. Deletion of band 13q21 is compatible with normal phenotype. Hum Genet. 70:1985;87-91.
20. Motegi T., Kaga M., Yanagawa Y., Kadowaki H., Watanabe K., Inoue A., Komatsu M., Minoda K. A recognizable pattern of the midface of retinoblastoma patients with interstitial deletion of 13q. Hum Genet. 64:1983;160-162.
21. Cavenee W.K., Hansen M.F., Nordenskjold M., Kock E., Maumenee I., Squire J.A., Phillips R.A., Gallie B.L. Genetic origin of mutations predisposing to retinoblastoma. Science. 228:1985;501-503.
22. Yandell D.W., Campbell T.A., Dayton S.H., Petersen R., Walton D., Little J.B., McConkie-Rosell A., Buckley E.G., Dryja T.P. Oncogenic point mutations in the human retinoblastoma gene: their application to genetic counseling. N Engl J Med. 321:1989;1689-1695.
23. Sandberg A.A., Turc-Carel C. The cytogenetics of solid tumors. Relation to diagnosis, classification and pathology. Cancer. 59:1987;387-395.
24. Heim S., Mitelman F. Cancer cytogenetics. 1995;Wiley-Liss, Inc. New York.
25. Gardner H.A., Gallie B.L., Knight L.A., Phillips R.A. Multiple karyotypic changes in retinoblastoma tumor cells: presence of normal chromosome no. 13 in most tumors. Cancer Genet Cytogenet. 6:1982;201-211.
26. Cano J., Oliveros O., Yunis E. Phenotypic variants, malignancy and additional copies of 6p in retinoblastoma. Cancer Genet Cytogenet. 76:1994;112-115.
27. Chen D., Gallie B.L., Squire J.A. Minimal regions of chromosomal imbalance in retinoblastoma detected by comparative genomic hybridization. Cancer Genet Cytogenet. 129:2001;57-63.
28. Mairal A., Pinglier E., Gilbert E., Peter M., Validire P., Desjardins L., Doz F., Aurias A., Couturier J. Detection of chromosome imbalances in retinoblastoma by parallel karyotype and CGH analyses. Genes Chromosomes Cancer. 28:2000;370-379.
29. Coignet L.J., Lima C.S., Min T., Streubel B., Swansbury J., Telford N., Swanton S., Bowen A., Nagai M., Catovsky D., Fonatsch C., Dyer M.J. Myeloid- and lymphoid-specific breakpoint cluster regions in chromosome band 13q14 in acute leukemia. Genes Chromosomes Cancer. 25:1999;222-229.
30. Kallioniemi A., Kallioniemi O.P., Waldman F.M., Chen L.C., Yu L.C., Fung Y.K., Smith H.S., Pinkel D., Gray J.W. Detection of retinoblastoma gene copy number in metaphase chromosomes and interphase nuclei by fluorescence in situ hybridization. Cytogenet Cell Genet. 60:1992;190-193.
31. Stratton M.R., Moss S., Warren W., Patterson H., Clark J., Fisher C., Fletcher C.D., Ball A., Thomas M., Gusterson B.A., Cooper C.S. Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RB1 gene. Oncogene. 5:1990;1297-1301.
32. Chibon F., Mairal A., Freneaux P., Terrier P., Coindre J.M., Sastre X., Aurias A. The RB1 gene is the target of chromosome 13 deletion in malignant fibrous histiocytoma. Cancer Res. 60:2000;6339-6345.
33. Yunis J.J., Soreng A.L. Constitutive fragile sites and cancer. Science. 226:1984;1199-1204.
34. Kok K., Osinga J., Carritt B., Davis M.B., Van Der Hout A.H., Van Der Veen A.Y., Landsvater R.M., De Leij L.F.M.H., Berendsen H.H., Postmus P.E., Poppema S., Buys C.H.C.M. Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancer. Nature. 330:1987;578-581.
35. Vogelstein B., Fearon E.R., Hamilton S.R., Kern S.E., Preisinger A.C., Leppert M., Nakamura Y., White R., Smits A.M., Bos J.L. Genetic alterations during colorectal-tumor development. N Engl J Med. 319:1988;525-532.
36. Nishimura A. The timing of cell division: Ap4 A as a signal. Trends Biochem Sci. 23:1998;157-159.
37. Ried K., Finnis M., Hobson L., Mangelsdorf M., Dayan S., Nancarrow J.K., Woollatt E., Kremmidiotis G., Gardner A., Venter D., Baker E., Richards R.I. Common chromosomal fragile site FRA16D sequence: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells. Hum Mol Genet. 9:2000;1651-1663.
38. Bednarek A.K., Laflin K.J., Daniel R.L., Liao Q., Hawkins K.A., Aldaz C.M. WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer. Cancer Res. 60:2000;2140-2145.
39. Chen D, Ducket A, Squire JA, Gallie BL. The novel human kinesin-like gene RBKIN cloned from the 0.5 mb minimal region of chromosome 6p22 gain is a candidate oncogene in retinoblastoma. Abstract book, Xth International Symposium on Retinoblastoma. Fort Lauderdale, FL, May 4, 2001.
40. Thorland E.C., Myers S.L., Persing D.H., Sarkar G., McGovern R.M., Gostout B.S., Smith D.I. Human papilloma virus type 16 integrations in cervical tumors frequently occur in common fragile sites. Cancer Res. 60:2000;5916-5921.
41. Szuhai K., Bezrookove V., Weigant J., Vroliik J., Resenberg C., Raap A.K., Tamke H. Simultaneous molecular karyotyping and mapping of viral integration sites by 25 colour COBRA-FISH. Genes Chromosomes Cancer. 28:2000;92-97.
42. Gallie B.L., Campbell C., Devlin H., Duckett A., Squire J.A. Developmental basis of retinal-specific induction of cancer by RB mutation. Cancer Res. 59:(Suppl):1999;1731S-1735S.
43. Turleau C., de Grouchy J., Chavin-Colin F., Junien C., Seger J., Schlienger P., Leblanc A., Haye C. Cytogenetic forms of retinoblastoma: their incidence in a survey of 66 patients. Cancer Genet Cytogenet. 16:1985;321-334.
44. Lohmann D.R., Gerick M., Brandt B., Oelschlager U., Lorenz B., Passarge E., Horsthemke B. Constitutional RB1-gene mutations in patients with isolated unilateral retinoblastoma. Am J Hum Genet. 61:1997;282-294.
45. Ejima Y., Sasaki M.S., Kaneko A., Tanooka H. Types, rates, origin and expressivity of chromosome mutations involving 13q14 in retinoblastoma patients. Hum Genet. 79:1988;118-123.
46. Arbetman A., Abdala M., Fandino A., Herrera J., Baranzini S., Borelina D., Parma D., Manzitti J., Barreiro C., Giliberto F., Szijan I. Clinical, cytogenetic, and molecular testing of Argentine patients with retinoblastoma. Journal of the American Association of Pediatric Ophthamology and Strabismus. 2:1998;102-107.
47. Ribeiro M.C., Andrade J.A., Erwenne C.M., Brunoni D. Bilateral retinoblastoma associated with 13q-mosaicism. Possible manifestation of a germinal mutation. Cancer Genet Cytogenet. 32:1988;169-175.
48. Greger V., Passarge E., Horsthemke B. Somatic mosaicism in a patient with bilateral retinoblastoma. Am J Hum Genet. 46:1990;1187-1193.
49. Blanquet V., Turleu C., Gross-Morand M.S., Senamaud- Beaufort C., Doz F., Besmond C. Spectrum of germline mutations in the RB1 gene; a study of 232 patients with hereditary and non-hereditary retinoblastoma. Hum Mol Genet. 4:1995;383-388.
50. Sippel K.C., Fraioli R.E., Smith G.D. Schalkoff, Sutherland J, Gallie B, Dryja TP. Frequency of somatic and germline mosaicism in retinoblastoma: implications for genetic counseling. Am J Hum Genet. 62:1998;610-619.
51. Draper G.J., Sanders B.M., Brownbill P.A., Hawkins M.M. Patterns of risk of hereditary retinoblastoma and applications to genetic counseling. Br J Cancer. 66:1992;211-219.
52. Damjanovich J., Adany R., Berta A., Beck Z., Balazs M. Mutation of the RB1 gene caused unilateral retinoblastoma in early age. Cancer Genet Cytogenet. 119:2000;1-7.
53. Lohmann D.R., Horsthemke B. No association between the presence of a constitutional RB1 gene mutation and age in 68 patients with isolated unilateral retinoblastoma. Eur J Cancer. 35:1999;1035-1036.